Thursday, May 14, 2026 | 08:15 PM ISTहिंदी में पढें
Vyome Biosciences
Tata-backed Impetis licenses JAK inhibitor assets to Vyome Holdings
Deal gives Vyome entry into the fast-growing market for next-generation autoimmune and inflammatory disease drugs
 "Tata-backed Impetis licenses JAK inhibitor assets to Vyome Holdings")
Updated On : 13 May 2026 | 4:21 PM IST
Vyome Biosciences raises $14 million in Series-C funding
Vyome is an innovation driven clinical stage bio-pharmaceutical company, which has a pipeline of novel drugs for antibiotic resistant acne
 "Vyome Biosciences raises $14 million in Series-C funding")
Updated On : 30 Jan 2018 | 3:08 PM IST